In this issue:
- New Zealand research:
– Smoking among adolescents pre/post vaping
– Equity gap in access to early lung cancer diagnosis
- Australian research:
– Real-world outcomes of pembrolizumab monotherapy in NSCLC
– Real-world effects of a clinical quality registry on cancer quality measures
- SABR:
– Compared with surgery in sarcoma-pulmonary metastases
– Combined with nivolumab in NSCLC
- Pembrolizumab without radiation in NSCLC
- Ivonescimab vs tislelizumab in squamous cell NSCLC
- Treatment of EGFR-mutant NSCLC:
– Savolitinib plus osimertinib
– Sacituzumab tirumotecan
Please login below to download this issue (PDF)